Jennifer Taubert - Johnson Johnson Chairman

JNJ Stock  ARS 11,500  25.00  0.22%   

Chairman

Ms. Jennifer L Taubert is the Executive Vice President Worldwide Chairman, Pharmaceuticals of the Company. She has joined the Company in 2005 as Worldwide Vice President at Johnson Johnson Pharmaceutical Services, a subsidiary of the Company. She held several executive positions in the Pharmaceutical sector until 2012 when she was appointed Company Group Chairman, North America Pharmaceuticals, and in 2015 became Company Group Chairman, The Americas, Pharmaceuticals. In July 2018, Ms. Taubert was promoted to Executive Vice President, Worldwide Chairman, Pharmaceuticals, and became a member of the Executive Committee. since 2018.
Age 59
Tenure 6 years
Phone732 524 0400
Webhttps://www.jnj.com

Johnson Johnson Management Efficiency

The company has return on total asset (ROA) of 0.0881 % which means that it generated a profit of $0.0881 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2414 %, meaning that it generated $0.2414 on every $100 dollars invested by stockholders. Johnson Johnson's management efficiency ratios could be used to measure how well Johnson Johnson manages its routine affairs as well as how well it operates its assets and liabilities.
Johnson Johnson Co has accumulated 29.98 B in total debt with debt to equity ratio (D/E) of 51.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Johnson Johnson has a current ratio of 1.41, which is within standard range for the sector. Debt can assist Johnson Johnson until it has trouble settling it off, either with new capital or with free cash flow. So, Johnson Johnson's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Johnson Johnson sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Johnson to invest in growth at high rates of return. When we think about Johnson Johnson's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 11 records

CHAIRMAN Age

Eduardo ElsztainIRSA Propiedades Comerciales
63
Raul RodriguezMetrogas SA
N/A
Patricio ReMetrogas SA
N/A
Juan VivancoMolinos Agro SA
N/A
Robert JDMerck Company
56
Alejandro ElsztainIRSA Propiedades Comerciales
57
Luis CompancMolinos Agro SA
N/A
Dante KoganMetrogas SA
N/A
Kenneth FrazierMerck Company
67
Eduardo BaldiMetrogas SA
N/A
Fernando AmbroaMetrogas SA
N/A
Johnson Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. The company was incorporated in 1887 and is based in New Brunswick, New Jersey. JOHNSON JOHNSON operates under Drug Manufacturers - Major classification in Argentina and is traded on Buenos-Aires Stock Exchange. It employs 135100 people. Johnson Johnson Co (JNJ) is traded on Buenos Aires Exchange in Argentina and employs 35 people.

Management Performance

Johnson Johnson Leadership Team

Elected by the shareholders, the Johnson Johnson's board of directors comprises two types of representatives: Johnson Johnson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Johnson. The board's role is to monitor Johnson Johnson's management team and ensure that shareholders' interests are well served. Johnson Johnson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Johnson Johnson's outside directors are responsible for providing unbiased perspectives on the board's policies.
Dirk Brinckman, Chief Officer
Robert Decker, Controller Officer
Alex Gorsky, Chairman, CEO, Chairman of Executive Committee and Chairman of Fin. Committee
Jessica Moore, VP Relations
Joaquin Duato, Executive Vice President Worldwide Chairman - Pharmaceuticals
Joseph CPA, Ex CFO
James Swanson, Ex Officer
Elizabeth Forminard, Exec Counsel
Jennifer Taubert, Executive Vice President - Worldwide Chairman, Pharmaceuticals
Peter Fasolo, Vice President - Global Human Resources

Johnson Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Johnson Johnson a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Johnson Stock

Johnson Johnson financial ratios help investors to determine whether Johnson Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Johnson with respect to the benefits of owning Johnson Johnson security.